Product Program year 2025 Source: CMS Open Payments

MENTOR CPX 2 Breast Tissue Expander

Device Plastic Surgery

PDI 00081317002352

Open in the dashboard

General payments

$340,088

1,761 payments

Research payments

$37,792

2 payments

Through program year 2025, $340,088 in general payments and $37,792 in research payments were reported against MENTOR CPX 2 Breast Tissue Expander (Plastic Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $213,034 650
2024 General $32,925 438
2023 General $53,791 340
2022 General $16,251 146
2021 General $24,088 187
2021 Research $37,792 2

Breakdown

Who paid General payments · program years 2021–2025
  1. Mentor Worldwide LLC $337,250 1,738 payments
  2. Johnson and Johnson International $2,549 19 payments
  3. Medical Device Business Services, Inc. $282 3 payments
  4. Biosense Webster, Inc. $7 1 payment
Top recipients General payments · program year 2025
  1. Caroline Glicksman Plastic Surgery · Sea Girt, NJ $19,536 9% · 12 payments
  2. Alexander Mericli Plastic Surgery · Houston, TX $17,570 8% · 13 payments
  3. Steven Williams Plastic Surgery · Stockton, CA $16,962 8% · 10 payments
  4. Samuel Lin Plastic Surgery · Boston, MA $14,982 7% · 11 payments
  5. Louis Strock Fort Worth, TX $14,695 7% · 13 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Plastic Surgery $142,565 74% · 160 practitioners
  2. Plastic and Reconstructive Surgery Surgery $33,470 17% · 89 practitioners
  3. Surgery of the Hand Plastic Surgery $12,693 7% · 7 practitioners
  4. Surgery $1,012 <1% · 13 practitioners
  5. Surgical Oncology Surgery $736 <1% · 6 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $43,482 20% · 78 recipients
  2. Texas $38,510 18% · 39 recipients
  3. New Jersey $20,754 10% · 13 recipients
  4. Florida $19,128 9% · 45 recipients
  5. Massachusetts $15,743 7% · 7 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,761 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record